공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

색전보호 기기 시장 : 예측(2021-2026년)

Embolic Protection Devices Market - Forecasts from 2021 to 2026

리서치사 Knowledge Sourcing Intelligence
발행일 2021년 10월 상품 코드 1013783
페이지 정보 영문 110 Pages
가격
US $ 3,950 ₩ 4,713,000 PDF (Single User License)
US $ 4,550 ₩ 5,429,000 PDF (Multiple User License)
US $ 6,950 ₩ 8,294,000 PDF (Enterprise License)


색전보호 기기 시장 : 예측(2021-2026년) Embolic Protection Devices Market - Forecasts from 2021 to 2026
발행일 : 2021년 10월 페이지 정보 : 영문 110 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

색전보호 기기 시장 시장 규모는 2019년 7억 6,400만 달러에서 2026년에는 12억 7,830만 9,000달러에 달하고, 예측기간 중 연평균 복합 성장률(CAGR) 7.63%의 성장이 예측됩니다. 심혈관, 말초현관, 신경혈관 수술 증가와 색전 기기 연구개발에 대한 높은 투자가 시장 성장을 촉진하는 주요인입니다.

세계의 색전보호 기기(Embolic Protection Device) 시장에 대해 조사분석했으며, 시장 역학, 부문별 시장 분석, 경쟁 환경, 주요 기업 등에 대한 정보를 전해드립니댜.

목차

제1장 서론

제2장 조사 방법

제3장 개요

제4장 시장 역학

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • Porter의 산업 분석
  • 업계 밸류체인 분석

제5장 색전보호 기기 시장 분석 : 유형별

  • 폐쇄 시스템
  • 필터 시스템

제6장 색전보호 기기 시장 분석 : 사용별

  • 관상동맥
  • 말초
  • 경동맥/신경
  • 신장

제7장 색전보호 기기 시장 분석 : 지역별

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 남미
    • 브라질
    • 아르헨티나
    • 기타
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 기타
  • 중동 및 아프리카
    • 사우디아라비아
    • 이스라엘
    • 기타
  • 아시아태평양
    • 중국
    • 일본
    • 한국
    • 인도
    • 태국
    • 인도네시아
    • 대만
    • 기타

제8장 경쟁 환경과 분석

  • 주요 기업과 전략적 분석
  • 신규 기업과 시장 수익성
  • 합병/인수/합의/협업
  • 벤더의 경쟁 메트릭스

제9장 기업 개요

  • Abott Laboratories
  • Boston Scientific Inc.
  • Medtronic Plc.
  • Gore Medical
  • Cardinal Health
  • Innovative Cardiovascular Solutions
  • Emboline Inc.
  • NIPRO
  • Silk Road Medical
  • Keystone Heart(Venus MedTech)
LSH 21.07.14

The embolic protection devices market is projected to grow at a CAGR of 7.63% to reach US$1,278.309 million by 2026, from US$764.000 million in 2019. During stenting, embolic protection devices (EPDs) collect blood and luminal debris within the SVG, minimizing distant embolization. It provides the most reliable evidence-based approach for preventing periprocedural MI and major adverse cardiovascular events (MACE) during SVG procedures. The number of problems caused by debris being released into the circulation and causing blockages in smaller arteries has decreased because of the introduction of embolic protection devices (EPD) during percutaneous cardiac operations. This device is meant to catch and remove any material that may become dislodged during operations. Embolic protection devices (EPDs) have the potential to minimize unfavorable clinical outcomes by preventing or reducing plaque particles from entering the distal bed. They are commonly utilized in carotid artery stenting and saphenous vein graft (SVG) procedures. They're also being tried in other vascular beds, such as the renal arteries, although their effectiveness in overcoming clinically relevant results has yet to be determined in these vascular beds.

The growing prevalence of cardiovascular and neurovascular disorders is driving the worldwide embolic protection devices market. More than 92 million Americans, according to the American Heart Association, have some kind of cardiovascular disease. The need for different surgical and non-surgical treatments would increase as the prevalence of cardiovascular illnesses rises. Other factors driving market expansion include an increase in the number of Trans-catheter Aortic Valve Replacement (TAVR) systems and increased consumer knowledge of embolic devices. Additional factors expected to boost the growth of the worldwide embolic protection devices market over the projected period include rising demand for less invasive procedures and technical improvements in embolic protection devices. Furthermore, government agencies, non-governmental organizations (NGOs), and educational institutions in many areas are initiating awareness campaigns to raise knowledge of cardiovascular and neurovascular illnesses and their possible treatments. This aspect is also influencing the market's growth.

The rising incidence of cardiovascular and neurovascular disorders in North America is expected to drive the adoption of embolic protection devices in the future years. Obesity, lifestyle trends, and bad eating habits are all expected to have a favorable impact on regional market growth. The sector's growth will be boosted even more by the strong presence of key industry participants in North America. The Asia Pacific region's expansion may be linked to the region's rapidly aging population, which is susceptible to a variety of neurological, cardiovascular, and other chronic illnesses. Segmental growth will be aided by urbanization, changing lifestyles, and rising incidence of risk factors such as obesity and hypertension in the region. In the future years, the Asia Pacific embolic protection devices business will be fueled by increased government backing and healthcare reforms in countries like China.

Growth Factors

Surging incidences of cardiovascular diseases will fuel the market growth.

One of the major reasons for the growth of the embolic protection devices market is rising incidences of cardiovascular diseases. The increase in the number of patients suffering from cardiovascular and neurovascular disorders is projected to propel the market forward. In a report by World Health Organization (WHO), CVDs claimed the lives of 17.9 million individuals worldwide in 2019, accounting for 32% of all fatalities. Heart attacks and strokes were responsible for 85 percent of these fatalities. Increased awareness of the need for pre-diagnostics and improved therapy would aid the industry in achieving maximum revenue in the near future. The worrisome rise in the number of deaths has drawn the attention of the government, which has resulted in an increase in public awareness campaigns. As the death rate from stroke rises, so will the number of surgical operations and drugs used to treat it. As a result, the market for embolic protection devices is expected to develop rapidly in the near future.

Restraints

High rate of product failure is expected to hinder the embolic protection devices market growth.

A major restraint in the growth of the embolic protection devices market is the high rate of product failure. The worldwide embolic protection devices market's growth is being held back by a high number of product failures and recalls. Another factor likely to hamper the global embolic protection devices market's growth during the projected period is the lack of adequate restitution policies for embolic protection devices. These factors account for the limited use of embolic protection devices and restrain its market growth.

Impact of COVID-19

The COVID-19 pandemic has had a great impact on the world as a whole and has led to economic breakdown and loss of life. Production activities are interrupted because of lockdown measures enforced in numerous countries. There have also been supplying chain interruptions and delays in the operations of enterprises. Trade barriers have restrained the stock. The COVID-19 impact on the embolic protection devices market has been negative owing to the production halt by industries due to the temporary lockdown implemented by several governments to break the cycle of the virus. The disruption in the demand and supply chain has further hampered the market in the forecast period. With the outbreak of viral illness and an increase in the number of COVID-19 cases throughout the world, demand for medical supplies continues to rise among healthcare professionals and the general public for preventive measures. As a result of the risk of infection spreading, surgical operations have been reduced, and the market for embolic protection devices is currently growing at a slower pace. The unfavorable conditions risen due to the COVID-19 virus have had a negative impact on the embolic protection devices market.

Competitive Insights

The market leaders for the pretreatment coating market are Abott Laboratories, Boston Scientific Inc., Medtronic Plc., Gore Medical, Cardinal Health, Innovative Cardiovascular Solutions, Emboline Inc., NIPRO, Silk Road Medical, and Keystone Heart (Venus MedTech).

Segmentation:

By Type

  • Occlusion Systems
  • Filter Systems

By Usage

  • Coronary Procedures
  • Peripheral Procedures
  • Carotid/Neurological Procedures
  • Renal Procedures

By Geography

  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Indonesia
    • Taiwan
    • Thailand
    • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Embolic Protection Devices Market Analysis, By Type

  • 5.1. Occlusion Systems
  • 5.2. Filter Systems

6. Embolic Protection Devices Market Analysis, By Usage

  • 6.1. Coronary Procedures
  • 6.2. Peripheral Procedures
  • 6.3. Carotid/Neurological Procedures
  • 6.4. Renal Procedures

7. Embolic Protection Devices Market Analysis, By Geography

  • 7.1. North America
    • 7.1.1. United States
    • 7.1.2. Canada
    • 7.1.3. Mexico
  • 7.2. South America
    • 7.2.1. Brazil
    • 7.2.2. Argentina
    • 7.2.3. Others
  • 7.3. Europe
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. United Kingdom
    • 7.3.4. Others
  • 7.4. The Middle East and Africa
    • 7.4.1. Saudi Arabia
    • 7.4.2. Israel
    • 7.4.3. Others
  • 7.5. Asia Pacific
    • 7.5.1. China
    • 7.5.2. Japan
    • 7.5.3. South Korea
    • 7.5.4. India
    • 7.5.5. Thailand
    • 7.5.6. Indonesia
    • 7.5.7. Taiwan
    • 7.5.8. Others

8. Competitive Environment and Analysis

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Emerging Players and Market Lucrativeness
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Vendor Competitiveness Matrix

9. Company Profiles

  • 9.1. Abott Laboratories
  • 9.2. Boston Scientific Inc.
  • 9.3. Medtronic Plc.
  • 9.4. Gore Medical
  • 9.5. Cardinal Health
  • 9.6. Innovative Cardiovascular Solutions
  • 9.7. Emboline Inc.
  • 9.8. NIPRO
  • 9.9. Silk Road Medical
  • 9.10. Keystone Heart (Venus MedTech)
Back to Top
전화 문의
F A Q